# Melanotan 2 Mechanism of Action: Melanocortin Receptors and the Eumelanin Cascade > Melanotan 2 mechanism of action: non-selective melanocortin-receptor agonism, the MC1R-cAMP-MITF eumelanin cascade, and the MC4R central effects on appetite and sexual function. How a cyclic alpha-MSH analog activates the five melanocortin receptors, drives eumelanin synthesis through MC1R, and produces its central effects through MC4R. ## In plain English The **Melanotan 2 mechanism of action** starts with imitation. The body makes a hormone, alpha-MSH, that tells cells to make pigment. Melanotan 2 is a tougher, stronger copy of it. When it reaches certain cell-surface switches — the melanocortin receptors — it flips them on, just like the natural hormone would, only harder and for longer. There are five of these switches. The one in the skin (MC1R) turns on tanning. The one in the brain (MC4R) turns down appetite and turns on sexual signaling. Melanotan 2 is not picky — it flips all five — which is why a single injection darkens skin, kills hunger, and triggers erections at the same time. Below, each switch is taken in turn: what it does, what happens downstream, and what the studies measured. The receptor-affinity details and the molecular identifiers follow the plain summary, unchanged. ## Non-selective melanocortin-receptor agonism Melanotan 2 is a non-selective agonist of the melanocortin receptor family — five G-protein-coupled receptors, MC1R through MC5R, that normally bind alpha-MSH and related peptides [1]. "Non-selective" is the operative word: rather than targeting one receptor, Melanotan 2 activates all five, which is the structural reason its effects are so broad [1]. MC1R governs pigmentation; MC3R and MC4R govern energy balance and appetite; MC4R also governs sexual function; MC5R is involved in exocrine-gland function [1]. The cyclic, lactam-bridged structure is what makes it superpotent and durable. By locking the seven-amino-acid chain into a ring, the design constrains its shape into a high-affinity binding conformation and shields it from the enzymes that rapidly degrade linear alpha-MSH [1]. The molecular identifiers — formula C50H69N15O9, CAS 121062-08-6, molecular weight ~1024.2 Da, and the sequence Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH2 — define the specific molecule under discussion [1]. ## MC1R and the eumelanin cascade Pigmentation is the MC1R story. When Melanotan 2 binds MC1R on a melanocyte, the receptor activates adenylyl cyclase, raising intracellular **cAMP** (cyclic adenosine monophosphate, a second-messenger molecule) [1]. cAMP activates protein kinase A (PKA), which phosphorylates the transcription factor CREB, which in turn upregulates **MITF** — the master transcription factor of the pigment-cell lineage [1]. MITF then switches on tyrosinase and the other enzymes of melanin synthesis, and the balance of output shifts toward **eumelanin**, the dark, brown-to-black, more photoprotective pigment, over the red-yellow pheomelanin [1]. The whole chain — MC1R to cAMP to PKA to CREB to MITF to tyrosinase to eumelanin — runs without any need for UV light to initiate it, which is the defining feature of the compound's tanning effect [1]. That the pigment produced is genuine eumelanin was confirmed in humans for the related analog Melanotan 1, where biopsies showed a significant eumelanin increase after dosing [4]. ## MC4R: appetite and sexual function The central effects run mainly through **MC4R** in the hypothalamus and the mesolimbic reward system [37][39]. Activating MC4R reduces food intake and the motivation to seek food — demonstrated directly in mice, where microinjecting Melanotan 2 into the nucleus accumbens cut both consumption and appetitive responding without causing taste aversion or changing metabolic rate [37]. The same central melanocortin signaling drives pro-erectile activity and sexual motivation, independent of the vascular pathways targeted by conventional erectile-dysfunction drugs [3]. In the controlled human study, Melanotan 2 produced centrally mediated erections in 8 of 10 men [3]; in female rats it increased proceptive sexual behaviors [39]. Central melanocortin signaling has also been shown to activate hypothalamic oxytocin neurons, an effect blocked by the melanocortin antagonist SHU-9119 — placing oxytocin downstream in the sexual and social-behavioral effects [39]. ## Why one molecule does so many things The breadth of Melanotan 2's effects is not a side issue — it is a direct, predictable consequence of the mechanism. Because the compound activates the entire melanocortin receptor family rather than one subtype, every tissue that carries a melanocortin receptor responds at once: skin pigments, the hypothalamus suppresses appetite, central circuits drive erections, and additional receptors influence energy expenditure and gland function [1]. This is also why the compound is hard to use cleanly. The pigmentation that users want and the appetite, sexual, cardiovascular, and pigment-lesion effects that come with it share the same root, so they cannot be dialed in independently [1]. The derivative bremelanotide (PT-141) was engineered to narrow this — shifting selectivity toward MC4R-mediated sexual effects with reduced pigmentation activity — precisely to escape Melanotan 2's non-selectivity [35]. The full set of distinct compounds and their differing receptor profiles is summarized in [melanotan 2 research](/research). --- A direct reading of the Melanotan 2 photoprotection literature — the eumelanin science and the documented harms set out side by side and cited, with no clinic, no product, and no dose behind the name.